Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / Provider Reviews / Oak Longevity Review
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Prices verified July 12, 2026·Methodology v1.0

Oak Longevity review (2026): pricing, programs, pros & limitations

Verdict

Oak advertises one flat price across all dosages with no membership and no subscription — semaglutide from $133/month and tirzepatide from $199 on the multi-month plan. That makes it the cheapest compounded semaglutide in our set. Not available in California. Month-to-month pricing is materially higher ($167–$299). This review reflects figures marked reported — pending verification as of July 12, 2026; where a figure is provider-reported we say so rather than presenting it as independently confirmed.

Provider snapshot

Oak Longevity snapshot — verification status per field, July 12, 2026
FieldDetailStatus
Starting price$133/mo semaglutide; $199 tirzepatideReported — pending verification
Renewal price$167–$299 month-to-monthReported — pending verification
Highest-dose priceFlat across all dosagesReported — pending verification
Membership fee$0 — no subscriptionReported — pending verification
LabsPhysician review includedReported — pending verification
ShippingIncludedReported — pending verification
CommitmentMulti-month plan for headline rateReported — pending verification
PharmacyNot independently verifiedReported — pending verification
ClinicianCare team + physician reviewReported — pending verification
States servedNOT available in CaliforniaReported — pending verification
Oak Longevity pricing across doses, July 12, 2026
$0$36$72$108$144Starting dose$133Every dose (flat)$133

Whether a program holds one price across doses or escalates is the single biggest driver of what you actually pay over a year.

Pricing analysis

Oak advertises one flat price across all dosages with no membership and no subscription — semaglutide from $133/month and tirzepatide from $199 on the multi-month plan. That makes it the cheapest compounded semaglutide in our set.

Limitation: Not available in California. Month-to-month pricing is materially higher ($167–$299).

Medical oversight

A legitimate GLP-1 program requires a licensed clinician to review the patient's history before any prescription. Care team + physician review. Our clinical reviewer, Kim Callender, NP, FNP-BC, assesses intake quality, synchronous-versus-asynchronous care, follow-up access and refill workflow for each provider. Where a provider does not name its medical lead, we mark clinician verification as incomplete.

Pharmacy and sourcing

Pharmacy transparency is one of the strongest legitimacy signals. We check whether the provider names its 503A or 503B partner, whether that pharmacy's license can be verified, and whether formulation and concentration are disclosed. For Oak Longevity: Not independently verified.

Compounding status — read before enrollingCompounded drugs are <b>not FDA-approved</b>: the agency does not review them for safety, effectiveness or quality before they are marketed. Federal law also bars compounding drugs that are <b>essentially a copy</b> of a commercially available approved product — a bar that is lifted only while the drug is on the FDA shortage list. Both shortages are over. The FDA declared the tirzepatide shortage resolved on October 2, 2024 and the semaglutide shortage resolved on February 21, 2025, and enforcement discretion ended for all compounders between February 18 and May 22, 2025. On April 30, 2026 the FDA went further, proposing to exclude semaglutide, tirzepatide and liraglutide from the 503B bulks list on a finding of no clinical need. Routine compounding of these molecules is therefore no longer lawful on the basis that made the market — a fact most comparison sites still describe as "permanent legitimacy." It is not.

Advantages and limitations

Advantages

  • Oak Longevity: Oak advertises one flat price across all dosages with no membership and no subscription — …
  • Pricing structure is disclosed clearly enough to evaluate
  • Clinician oversight is stated

Limitations

  • Not available in California. Month-to-month pricing is materially higher ($167–$299).
  • Pharmacy partner not independently verified by us yet

Evidence ledger

Every material claim on this page traces to a source, a capture date and a verification status.

Evidence ledger — claim, source, date checked, status
ClaimSourceCheckedStatus
Starting priceProvider plan documentationJuly 12, 2026Reported — pending verification
Pharmacy partnerProvider disclosureJuly 12, 2026Reported — pending verification
Clinician / medical leadProvider disclosureJuly 12, 2026Reported — pending verification
Shipping termsProvider terms pageJuly 12, 2026Reported — pending verification
State availabilityProvider disclosureJuly 12, 2026Evaluation in progress

Alternatives to consider

Compare Oak Longevity against NexLife · Found · LillyDirect. For the full field, see best GLP-1 programs and most affordable compounded tirzepatide.

Provider response

Oak Longevity may submit factual corrections through our corrections process. Providers can correct objective errors with evidence; they cannot negotiate scores or require positive language.

Frequently asked questions

Is Oak Longevity legitimate?

Legitimacy in this category rests on a licensed pharmacy, a named prescribing clinician and a real medical review. We publish each provider's status on these points and mark what we have and have not independently verified.

How much does Oak Longevity cost?

$133/mo semaglutide; $199 tirzepatide to start (reported — pending verification). See the pricing section for renewal and highest-dose figures.

Does Oak Longevity require a prescription?

Yes. Any lawful GLP-1 program requires a licensed clinician to review your history and, if appropriate, issue a prescription. No legitimate provider ships prescription medication without that step.

Sources

  1. Provider website, terms, pricing and pharmacy-disclosure pages (captured July 12, 2026).
  2. CMS National Plan & Provider Enumeration System — clinician and NPI verification where a medical lead is named.
  3. U.S. Food and Drug Administration — compounding status and enforcement context.
  4. Our published scoring methodology, version 1.0.

Spotted an error? Submit a correction.